|
EIF4ENIF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.321800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.008500E-02 |
| Normal-vs-Stage2 |
1.774040E-01 |
| Normal-vs-Stage3 |
7.520200E-01 |
| Normal-vs-Stage4 |
1.483340E-03 |
| Stage1-vs-Stage2 |
6.669200E-01 |
| Stage1-vs-Stage3 |
2.982600E-01 |
| Stage1-vs-Stage4 |
1.000450E-04 |
| Stage2-vs-Stage3 |
3.016200E-01 |
| Stage2-vs-Stage4 |
4.475300E-03 |
| Stage3-vs-Stage4 |
1.206050E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.220020E-02 |
| Normal-vs-AfricanAmerican |
5.662100E-02 |
| Normal-vs-Asian |
2.487600E-01 |
| Caucasian-vs-AfricanAmerican |
8.701600E-01 |
| Caucasian-vs-Asian |
2.094200E-01 |
| AfricanAmerican-vs-Asian |
2.040800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.699800E-03 |
| Normal-vs-Female |
9.834000E-02 |
| Male-vs-Female |
9.133200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.896200E-01 |
| Normal-vs-Extreme_Weight |
2.336000E-01 |
| Normal-vs-Obese |
8.701000E-03 |
| Normal-vs-Extreme_Obese |
7.461000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.487400E-01 |
| Normal_Weight-vs-Obese |
1.474380E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.789000E-01 |
| Extreme_Weight-vs-Obese |
9.406500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.082600E-01 |
| Obese-vs-Extreme_Obese |
3.265000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.377200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.201200E-03 |
| Normal-vs-Age(61-80Yrs) |
2.411700E-02 |
| Normal-vs-Age(81-100Yrs) |
8.431800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.663800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.029400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.636400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.640600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.874640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.756800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.28270000002251E-06 |
| Normal-VS-Type2 PRCC |
5.821200E-01 |
| Normal-VS-KIRP CIMP |
7.710400000005E-05 |
| Normal-VS-Unclassified PRCC |
1.820380E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.88274999999294E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.07400000016034E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.011830E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.762840E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.146770E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.69620000000693E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.616600E-01 |
| Normal-vs-N1 |
9.029800E-01 |
| Normal-vs-N2 |
1.511000E-01 |
| N0-vs-N1 |
9.524600E-01 |
| N0-vs-N2 |
3.574000E-01 |
| N1-vs-N2 |
5.031000E-01 |
|
|
